EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,543 | -24.0% | 5,066 | 0.0% | 0.00% | – |
Q4 2022 | $5,978 | -84.3% | 5,066 | 0.0% | 0.00% | – |
Q3 2022 | $38,000 | +40.7% | 5,066 | +17.1% | 0.00% | – |
Q2 2022 | $27,000 | +22.7% | 4,327 | +62.0% | 0.00% | – |
Q1 2022 | $22,000 | +57.1% | 2,671 | 0.0% | 0.00% | – |
Q4 2021 | $14,000 | -22.2% | 2,671 | 0.0% | 0.00% | – |
Q3 2021 | $18,000 | -21.7% | 2,671 | 0.0% | 0.00% | – |
Q2 2021 | $23,000 | -25.8% | 2,671 | -24.3% | 0.00% | – |
Q1 2021 | $31,000 | -31.1% | 3,528 | -3.8% | 0.00% | – |
Q4 2020 | $45,000 | +66.7% | 3,669 | +10.4% | 0.00% | – |
Q3 2020 | $27,000 | -28.9% | 3,322 | -16.1% | 0.00% | – |
Q2 2020 | $38,000 | +40.7% | 3,959 | -0.9% | 0.00% | – |
Q1 2020 | $27,000 | -62.5% | 3,993 | -17.2% | 0.00% | – |
Q4 2019 | $72,000 | +80.0% | 4,822 | +23.3% | 0.00% | – |
Q3 2019 | $40,000 | -2.4% | 3,912 | 0.0% | 0.00% | – |
Q2 2019 | $41,000 | +310.0% | 3,912 | +327.5% | 0.00% | – |
Q1 2017 | $10,000 | 0.0% | 915 | 0.0% | 0.00% | – |
Q4 2016 | $10,000 | – | 915 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 595,238 | $4,845,000 | 3.97% |
P.A.W. CAPITAL CORP | 360,000 | $2,930,000 | 3.19% |
Telemetry Investments, L.L.C. | 124,320 | $1,012,000 | 2.20% |
Soleus Capital Management, L.P. | 472,558 | $3,847,000 | 2.04% |
Copernicus Capital Management, LLC | 238,151 | $1,939,000 | 1.85% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,226,000 | 1.80% |
Trellus Management Company, LLC | 200,000 | $1,628,000 | 1.67% |
683 Capital Management, LLC | 2,622,914 | $21,350,000 | 1.56% |
KNOTT DAVID M | 275,348 | $2,241,000 | 1.32% |
MANGROVE PARTNERS IM, LLC | 1,092,394 | $8,892,000 | 1.12% |